Business description: Bristol-Myers Squibb Company

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.

The United States account for 70.1% of net sales.

Number of employees: 34,100

Sales by Activity: Bristol-Myers Squibb Company

Fiscal Period: December20192020202120222023

Pharmaceuticals

26.14B 42.52B 46.38B 46.16B 45.01B
See all business segments

Geographical breakdown of sales: Bristol-Myers Squibb Company

Fiscal Period: December20192020202120222023

United States

15.34B 26.58B 29.21B 31.83B 31.56B

International

- - - 13.5B 12.75B

Unallocated

524M 631M 852M 834M 699M

Europe

6.27B 9.85B 10.69B - -

Rest of The World

4.01B 5.46B 5.63B - -
See all geographic segments

Managers: Bristol-Myers Squibb Company

Director TitleAgeSince
Chief Executive Officer 53 2023-10-31
Director of Finance/CFO 56 2019-11-19
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 2023-09-30
See BRISTOL-MYERS SQUIBB COMPANY governance

Members of the board: Bristol-Myers Squibb Company

Manager TitleAgeSince
Chairman 53 2024-03-31
Director/Board Member 59 2016-03-31
Director/Board Member 69 2017-02-20
Director/Board Member 66 2017-12-31
Director/Board Member 69 2019-11-19
Director/Board Member 66 2019-11-19
Director/Board Member 62 2020-08-31
Director/Board Member 59 2020-08-31
Director/Board Member 56 2021-05-31
Director/Board Member 56 2022-06-13
Composition of the Board of Directors

Shareholders: Bristol-Myers Squibb Company

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.203 %
186,571,157 9.203 % 9 653 M $
BlackRock Advisors LLC
6.052 %
122,692,944 6.052 % 6 348 M $
91,445,366 4.510 % 4 731 M $
JPMorgan Investment Management, Inc.
3.675 %
74,498,757 3.675 % 3 855 M $
Capital Research & Management Co. (International Investors)
2.733 %
55,406,592 2.733 % 2 867 M $
NameEquities%Valuation
Mercer Global Investments Europe Ltd.
0.0100 %
203,425 0.0100 % 10 M $
Bram Bradesco Asset Management S/A DTVM
0.000228 %
4,631 0.000228 % 233 344 $
NameEquities%Valuation
Transcend Capital Advisors LLC
-
117,775 - 5 653 $
FourWorld Capital Management LLC
-
100,000 - 4 800 $
Davenport & Co. LLC
-
83,970 - 4 031 $
Watts Gwilliam & Co. LLC
-
20,000 - 960 $
20,000 - 960 $
List of BRISTOL-MYERS SQUIBB COMPANY shareholders

Holdings: Bristol-Myers Squibb Company

NameEquities%Valuation
5,075,3044.33%233,108,713 $
11,006,1639.17%42,593,851 $
759,1456.29%33,873,050 $
70,231,14016.92%16,726,951 $
4,757,0585.31%8,610,275 $
1,195,3275.49%3,550,121 $

Company details: Bristol-Myers Squibb Company

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com
address Bristol-Myers Squibb Company(BMY)

Group companies: Bristol-Myers Squibb Company

NameCategory and Sector
Bristol-Myers Squibb SA (Spain)
Medical Distributors
Bristol-Myers Squibb AE
Pharmaceuticals: Major
BMS Strategic Portfolio Investments Holdings, Inc.
Pharmaceuticals: Generic
See all subsidiaries

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-2.60%+4.62%+6.24%-7.35%110B
-1.30%-8.26%+41.12%+218.84%736B
+0.76%-1.96%+8.37%+115.38%496B
+0.17%-0.47%+6.58%-3.30%386B
-0.16%+8.36%+42.08%+74.68%360B
-0.43%-2.02%-0.94%+14.45%258B
+1.94%-2.88%+14.68%-25.68%253B
-0.18%-5.03%+6.37%+16.92%221B
+1.80%-3.21%+12.79%+24.27%219B
-0.29%+0.71%+19.74%+48.99%172B
Average -0.03%-1.01%+15.70%+47.72% 321.12B
Weighted average by Cap. -0.05%-2.08%+19.89%+80.29%
See all sector performances
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Company Bristol-Myers Squibb Company